Becoming an Author- Part 2: The Peer Review Process
PART 2
We at Next Steps are very excited to announce that the Executive Editor of our media partner, the Journal of Drugs in Dermatology, will be providing expert advice and tips on getting published. Karin Beehler, who has over 25 years of publishing experience, will share her extensive knowledge and expertise with our Next Steps readers in this 2-part series.
Peer review proces …
PART 2
We at Next Steps are very excited to announce that the Executive Editor of our media partner, the Journal of Drugs in Dermatology, will be providing expert advice and tips on getting published. Karin Beehler, who has over 25 years of publishing experience, will share her extensive knowledge and expertise with our Next Steps readers in this 2-part series.
Peer review proces … Continue reading "Becoming an Author- Part 2: The Peer Review Process"
JDD Dermatology Podcasts present the latest JDD journal content related to advances in drugs, devices and treatment methods in dermatology, in a new convenient audio format. From article abstracts to interviews, JDD Dermatology Podcasts provide a fresh perspective of the peer reviewed content you have come to rely on from JDD (Journal of Drugs in Dermatology).
Hosted by Adam Friedman, … 
Because keeping up with the latest and greatest in the world of dermatology literature is no easy feat. The breadth of information is staggering and with the pressures of increasing patient loads to combat the tumultuous changes in healthcare, who has time to sit back, relax, and read every dermatology journal? Given the speed at which new research translates into new diagnostics and treatments, f … 
Mainstream medical dermatology is changing, and it’s about time, says Dr. R. Rox Anderson, professor at Harvard Medical School and director of the Wellman Center for Photomedicine at Massachusetts General Hospital. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Anderson about the future of product innovation. Hear what Dr. Anderson … 
Ciclopirox is the only hydroxypyridone antifungal agent with a unique mechanism of action differentiating it from other antimycotic agents. Unlike the azole-antifungals which block the sterol synthesis in the fungal cell membrane, ciclopirox functions by chelating cations resulting in the degradation of fungal cells, as well as proposed anti-inflammatory properties. It is available in a variety of … 